Ginkgo Bioworks Holdings, Inc. (DNA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $611.11M | -7.6% |
| 2024 | $661.39M | +16.4% |
| 2023 | $568.19M | -29.2% |
| 2022 | $803.04M | +59.5% |
| 2021 | $503.61M | +145.5% |
| 2020 | $205.10M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $611.11M | -7.6% |
| 2024 | $661.39M | +16.4% |
| 2023 | $568.19M | -29.2% |
| 2022 | $803.04M | +59.5% |
| 2021 | $503.61M | +145.5% |
| 2020 | $205.10M | — |